The Global Market for Pain Management Drugs and Devices

Jan 2013| HLC026D| BCC Publishing

Report Highlights

The market for pain management drugs and devices was valued at $35.4 billion in 2012. Total market valued is expected to reach $41.5 billion in 2017 after increasing at a five-year compound annual growth rate of 3.2%.

Report Includes

  • An overview of the global market for pain management drugs, which will address acute vs. chronic pain, treatments, and issues facing healthcare workers.
  • Analyses of global market trends, with data from 2012, and projections of compound annual growth rates (CAGRs) through 2017.
  • Examination of product categories, use of products, and the competitive landscape.
  • Coverage of several significant market trends, including undertreatment issues, professional issues, managed care pain issues, trends in new therapies, product pipelines, generic participation, pain research, drug delivery, and patent expirations.
  • Discussion of new regulatory requirements.
  • Comprehensive company profiles of major players in the industry.

SCOPE AND FORMAT

This BCC Research report is designed to be a helpful business tool that will provide a thorough evaluation of the markets for pain management.  The geographical scope of this study is global with a U.S. emphasis.  This study will address acute versus chronic pain, treatments, and regulatory issues facing healthcare workers.  Also provided is detailed information based on product categories, use of products, forecasts, and competitive analyses.

The report identifies two general segments of pain management:

  • Pharmaceuticals.
  • Devices.

Within the pharmaceuticals segment several sub-segments are discussed in detail including:

  • Narcotic pain management.
  • Non-narcotic pain management.
  • Antimigraine treatments.
  • Anesthetics.
  • Other drugs (including fibromyalgia treatments).

The device segment covers several product lines and specifically targets the largest product segments including:

  • TENS and neuromuscular stimulators.
  • Spinal cord stimulators.
  • Other products (including electromagnetic therapies and other treatments).

Each market segment provides detailed information based on product categories, product use, forecasts, and competitive analyses.

Analyst Credentials

Melissa Elder is an experienced healthcare market analyst specializing in medical treatments, equipment and devices. Ms. Elder holds an MBA in Health Care Management and provides consultation to various institutions globally. She has been involved in the healthcare industry since 1996, providing more than 23 years of industry expertise. Ms. Elder has specialized in market research for more than 20 years, focusing on the areas of advanced medical technologies, biological products and animal health. In-depth analysis into more than 100 health-related topics has given Ms. Elder substantial insight into industry dynamics, market influences and future direction of various health markets. Her work in the medical community, including emergency room medical training and healthcare information system coordination, has enhanced her ability to provide insight into many healthcare specialties. She has authored several industry-specific documents and is a well-respected contributor to the market research community. Her writings are published in magazines, newspapers and professional journals. She is also an experienced custom market research writer who has worked with a large variety of clients in many fields who require innumerable variations to research documents.

Latest reports include:

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter Name Pages Price Member Price
Full Report: The Global Market for Pain Management Drugs and Devices 221 $2,750 Free
Chapter- 1: INTRODUCTION3Free
Chapter- 2: SUMMARY5$250Free
Chapter- 3: INDUSTRY OVERVIEW39$485Free
Chapter- 4: INDUSTRY TRENDS42$523Free
Chapter- 5: TREATING PAIN43$535Free
Chapter- 6: PRESCRIPTION PAIN MANAGEMENT MARKET SIZE AND ANALYSIS8$100Free
Chapter- 7: PAIN MANAGEMENT DEVICE MARKET SIZE AND ANALYSIS 5$62Free
Chapter- 8: TOTAL MARKET SUMMARY4$50Free
Chapter- 9: INDUSTRY DEVELOPMENTS15$187Free
Chapter- 10: COMPANY PROFILES8$100Free
Chapter- 11: APPENDIX I: SELECTED PAIN MANAGEMENT CLINICS-UNITED STATES-BY STATE28$348Free
Chapter- 12: APPENDIX II: GLOBAL SELECTED PAIN MANAGEMENT CLINICS, BY COUNTRY9$112Free
Chapter- 13: APPENDIX III: U.S. PAIN SOCIETIES AND ASSOCIATIONS1$12Free
Chapter- 14: APPENDIX IV: INTERNATIONAL ASSOCIATIONS AND ORGANIZATIONS1$12Free
Chapter- 15: APPENDIX V: COMPANY NAMES AND ADDRESSES10$124Free
Published - Aug-2009| Analyst - Melissa Elder| Code - HLC026C

Report Highlights

  • The global market for pain management pharmaceuticals and devices amounted to $19.1 billion in 2008 and is expected to increase to $32.8 billion in 2013. The compound annual growth rate (CAGR) for the 5-year period is projected at 11.5%.
  • The pharmaceuticals segment dominated the market at $17.6 billion in 2008. That figure is expected to increase to $30.2 billion in 2013, for a CAGR of 11.5%.
  • The devices segment of the market generated $1.48 billion in sales in 2008 and is projected to increase to $2.5 billion in 2013, for a CAGR of 11.4%.
Published - Jun-2007| Analyst - Alpita Shah| Code - HLC026B

Report Highlights

  • The global pain-management market is worth around $30.9 billion in 2007. It is forecasted to grow at a compound annual growth rate (CAGR) of 5.63% to reach $40.6 billion by the end of the forecast period, 2012.
  • The pharmaceuticals segment of the pain-management market is valued at $29 billion in 2007. It will be worth $38 billion by 2012 at a CAGR of 5.6%.
  • In 2007, market revenue from the medical devices segment is around $1.9 billion. This segment is predicted to grow at a CAGR of 6.5% to reach $2.6 billion by the end of 2012.
Published - Aug-2000| Analyst - Mary Anne Crandall| Code - HLC026A

Report Highlights

  • This report presents the forecast of the market for pain management through the year 2005. By 2005, it is anticipated that revenues will likely reach $32 billion, growing at an average annual rate of almost 12%.
  • Pain management pharmaceuticals currently hold the largest market revenue position, representing 97% and accounting for $16 billion of the total in 1999. Pharmaceuticals have long been the mainstay of pain management and it is anticipated that they will remain the largest market share throughout the forecast period.
  • Pain management devices account for 3%, representing $418.5 million in 1999. It is anticipated that the device segment will gain market revenue position due to technological advancements and a gradually declining cost increasing demand for current technologies

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS
Share This Report